$18.80
-0.28-1.49%
Last update: Nov 11, 3:40 PM
Innoviva Inc
INVANASDAQ
Innoviva fell 12.9% from $21.90 to $19.08, behind the S&P 500's +9.8%. Its worst day was Nov 5 (−9.5%), and its low came Nov 9 at $19.00.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Innoviva shares rose 4.9%, while the S&P 500 rose 0.5%.
+4.9% · S&P 500 +0.5%
Innoviva shares rose 5.1%, while the S&P 500 rose 0.2%.
+5.1%, the year's best day · S&P 500 +0.2%
Story events cover the past 12 months · Times ET
EPS of $1.94 beat the $0.39 estimate on $114.6M revenue (est. $102.2M).
−2.9% · S&P 500 −0.6%
EPS of $2.22 beat the $0.43 estimate on $98.0M revenue (est. $101.2M).
+1.2% · S&P 500 −0.3%
EPS of $-1.14 missed the $0.51 estimate on $119.6M revenue (est. $111.4M).
+2.9% · S&P 500 −0.2%
EPS of $-1.03 missed the $0.37 estimate on $106.1M revenue (est. $115.0M).
−9.5%, the year's worst day · S&P 500 −4.4%
Where it ended: a close of $19.08 on Nov 10, 2026. Up next: Q4 2026 earnings on Feb 24, 2027 (EPS est. $0.44, revenue est. $111.8M).
Nothing in the past 12 months.
All INVA dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for INVA and SPY from Benzinga historical bars. Not investment advice.
